05Immunoglobulin.ppt

上传人:本田雅阁 文档编号:3005849 上传时间:2019-06-23 格式:PPT 页数:90 大小:7.10MB
返回 下载 相关 举报
05Immunoglobulin.ppt_第1页
第1页 / 共90页
05Immunoglobulin.ppt_第2页
第2页 / 共90页
05Immunoglobulin.ppt_第3页
第3页 / 共90页
05Immunoglobulin.ppt_第4页
第4页 / 共90页
05Immunoglobulin.ppt_第5页
第5页 / 共90页
点击查看更多>>
资源描述

《05Immunoglobulin.ppt》由会员分享,可在线阅读,更多相关《05Immunoglobulin.ppt(90页珍藏版)》请在三一文库上搜索。

1、Chapter 5 Immunoglobulin,Contents,Introduction Section Molecular Structure of Ig Section Characteristics and Functions of the 5 Classes of Ig Section Fc Receptors for Ab Molecules Section Biological Activity of Ab Section Immunogenicity of Ig Section Artificial Ab,Concepts,Antibody (Ab): Glycoprotei

2、n molecules that are produced by plasma cells and can combine with the corresponding Ag specifically are called Ab. Ab is produced by B cells in the response to a stimulation of Ag. Ab possesses a high degree of specificity and affinity,Immunoglobulin(Ig): It refers to all globulins that possess the

3、 activity of Ab or show a similar structure to Ab Therefore, All Abs are Igs, but not all Igs possess the functions of Abs,Other Concepts,- Globulin Antiserum Humoral Immunity sIg and mIg(BCR),Section Molecular Structure of Ig,. Basic structure,Ig is composed of four polypeptide chains joined by S-S

4、 bonds. inter-chain disulfide bonds (S-S) intra-chain disulfide bonds (S-S) It shows “T” or “Y” shape.,(four polypeptide chains),1. H and L chain:,. Heavy chains (H): 450 550 aa, 50 75 KD . Light chains (L): 214 aa, 25 KD,Two terminal ends for each peptide chain “N” terminal end “C” terminal end L c

5、hains attach to H chains from “N” end,“N”,“C”,2. classes and types of Ig,(1) According to the differences of H chains (amino acid composition, sequence) Igs can be divided into 5 classes Five classes of H Chain: Five classes of Igs: IgG IgA IgM IgD IgE,subclasses,IgG1 IgG4,IgA1, IgA2,(2) According t

6、o the differences of L chains Two types of L chain: , : 20:1 (in mice); 2:1 (in human),subtypes, 1 4,3. Two regions of each peptide chain,(1) Constant region (C),(3) Hinge region,(2) Variable region (V),(1) Constant region ( C ) CH: 3/4 or 4/5 (,) of H chain from the c end CL: 1/2 of L chain from th

7、e c end (2) Variable region ( V ) CH: 1/4 or 1/5 (,) of H chain from the N end CL: 1/2 of L chain from the N end,3. Two regions of each peptide chain,(2) Variable region ( V ):,Hypervariable region(HVR) There are three highly diversity stretches within the V egion, they are called HVR. Framework reg

8、ion(FR): FR1-FR4,Ag-binding sites,Complementarity determining regions(CDR),(2) Variable region (V),Complementarity determining regions(CDR) L: CDR1, CDR2, CDR3 H: CDR1, CDR2, CDR3,Idiotype of Ig,Igs produced by different B cells possess unique structure respectively in hypervariable region (HVR), th

9、e unique structure of Ig is called idiotype or idiotypic determinant,In fact: HVR CDR Idiotype are in the same sites of Ig,(3) Hinge region: Flexible and suitable for CDR of Ig binding to antigenic determinants. Sensitive to proteolytic enzyme IgM, IgE,Other structures of Ig,Joining chain(J),Secreto

10、ry piece(SP),Joining chain(J ) :,Produced by plasma cells Functions:linker, to compose dimer、pentamer or polymer(IgA, IgM),Secretory piece( SP):,. Produced by mucosa epithelial cells . Secretory IgA (sIgA) . Functions: protect sIgA, resist proteolysis in extra secretory liquid.,IgA,. Domains of Ig,1

11、. Domain :,Polypeptide chains of Ig are folded into a globular structure by intra chain s-s bond within each 110aa region which is called a domain,2. Domains of Ig,L chain(2) : VL, CL H chain(45): VH, CH1, CH2, CH3 CH4(in IgM,IgE) hinge region,3. Function of each domain,VH, VL: antigen-binding site

12、CH1, CL: allogeneic marker CH2/CH3: complement-fixing site, permeate placenta(IgG) CH3/CH4: cell-binding site Hinge region :,flexible and suitable for CDR of Ig binding to antigenic determinants,. Hydrolytic fragments of Ig,Ig can be digested by papain and pepsin Position Fragments Function,1. Diges

13、ted by papain,Position: near the S-S bonds of H inter-chains fromthe N end Fragments: 2Fab:fragment antigen-binding Fc:fragment crystallizable Function: Fab: recognize and bind Ag Fc: (1) fix complement (2) crossing the placenta (3) bind to FcR in different cells,Ag:Ab ratio,2. Digested by pepsin Po

14、sition: near the S-S bond of H inter-chains from the C end Fragments and function : F(ab)2: bind antigen(2 valence) pFc: no function,Significance,Elucidating the relationships between the structure and function of Igs Decrease the immunogenicity of Ig for clinical treatment,Section Characteristics a

15、nd Functions of the 5 Classes of Igs,. IgG,1. Highest concentration in serum(75% of total Ig),2. Four subclasses: IgG1, IgG2, IgG3, IgG4,3. Unique Ig that can pass through placenta 4. Half-life is longer( 16-24 days ) 5. Starts to be produced at 2-3 month after birth and reach the level of adult at

16、5 years old,6. Functions of IgG: Against bacteria and virus,neutralize toxin Combine with the Fc receptor(FcR) Activate complement Combine with SPA Some belong to the auto-antibodies Take part in type and hypersensitivity,. IgM,1. Highest MW:pentamer(90 KD),10 valences,2. Half-life is shorter(45 day

17、s) 3. The first Ig to be synthesized Appear in the early stage after infection Be produced during fetus The first mIg of the B cells, act as the antigen receptors(BCR),4. Functions:,IgM is more effective in binding Ag and activating C, and play an important role in anti-infection Natural Ab for bloo

18、d-type antigen Auto-antibody: rheumatoid factor(RF) Take part in type and hypersensitivity,. IgA 1. Two types Serum type :monomer Secretary type(sIgA): dimer,trimer or polymer 2. Two subclasses:IgA1,IgA2,3. To be produced at 4 months after birth 4. Exist in almost all body fluid,6. Local mucosal imm

19、unity,Immune barrier Neutralize virus/toxin Rich in colostrum Activate C by alternative pathway Take part in type hypersensitivity,. IgD,1. The concentration in serum is low and sensitive to proteinase 2. Act as the antigen receptor on B cells (mIgD): Regulate the differentiation of B cells,. IgE,1.

20、Concerntration of IgE in serum is the lowest in normal individual, but is very high in some patients. 2.Related to typepersensitivity FcR: mast cell, basophil,Section Fc Receptors for Ab Molecules,IgG-FcR: FcR(CD64)-phagocyte FcR(CD32)-immune complex FcR(CD16)-NK,macrophage,T cell IgE-FcR: FcR- mast

21、 cell, basophil FcR- macrophage, B cell IgA-FcR(CD89)-phagocyte, neutrophil,Section Biological Activity of Ab,1. Recognize and bind to antigen specifically 2. Fix complement 3. Bind to Fc receptor on some cells 4. Transfer selectively : .Planceta transfer (IgG) .Mucosa transfer (sIgA),Affinity and A

22、vidity,Neutralization,IgM,IgG13: classical pathway IgA,IgG4,IgE: alternative pathway,MAC,(1) Opsonization(IgG, IgM): Enhance the phagocytosis of M,(2) ADCC( antibody dependent cell mediated cytotoxicity),(3) Hypersensitivity type - mast cell, basophil(FcR),Section Immunogenicity of Ig,Isotype: CH, C

23、L,Allotype:CH, CL,Idiotype: VH, VL Anti-idiotype antibody,Section Artificial Ab,Polyclonal Ab Monoclonal Ab Gene engineering Ab,1. Polyclonal Ab,A mixture Ab with different specificities and affinities Generate in a natural response or artificial immunization Cross reaction,Cross-reactivity: if two

24、antigens share an epitope an antibody recognizes an unrelated, but chemically similar, epitope,2. Monoclonal Ab (mAb),Ab produced by single clone (or one hybridomas clone ) and having a single specificity,mAb / McAb,Prepared by hybridomas technique: Immunized spleen cells(B) hybride with myeloma cel

25、ls-hybridomas,Artificial antibodies,Derived from different B Lymphocytes cell lines,POLYCLONAL.,MONOCLONAL.,Derived from a single B cell clone,Batch to Batch variation affecting Ab reactivity & titre,mAb offer Reproducible, Predictable & Potentially inexhaustible supply of Ab with exquisite specific

26、ity,Enable the development of secure immunoassay systems.,NOT Powerful tools for clinical diagnostic tests,Cell fusion technique:,Hybridoma cell,No Ab Long life,Secrete Ab Short life,Secrete Ab Long life,Khler and Milstein, 1975,1984, Nobel Prize,Screening of hybridoma cell:,Hybridoma cell,S/S,M/M,M

27、yeloma cell,splenocyte,HAT selective medium: 次黄嘌呤(hypoxanthine,H) 氨甲喋呤(aminopterin,A):叶酸拮抗剂 胸腺嘧啶核苷(thymidine,T),Screening with HAT selective medium:,H, 次黄嘌呤; A, 氨基喋呤; T, 胸腺嘧啶,A,(Hypoxanthine guznine phosphoribosyl transferase) 次嘌呤鸟嘌呤磷酸核糖转移酶 ( HGPRT ),胸腺嘧啶激酶 ( TK ) (Thymidine kinase),B cell: HGPRT+,

28、TK+,Myeloma cell: HGPRT-, TK-,live,die,Extrinsic pathway(minor),PRODUCTION OF MONOCLONAL ANTIBODY,HYBRIDOMA TECHNOLOGY,Applications of Monoclonal Antibodies,Diagnostic Applications Biosensors & Microarrays Therapeutic Applications Transplant rejection Muronomab-CD3 Cardiovascular disease Abciximab C

29、ancer Rituximab Infectious Diseases Palivizumab Inflammatory disease Infliximab Clinical Applications Purification of drugs, Imaging the target Future Applications Fight against Bioterrorism,EVOLUTION OF MONOCLONAL ANTIBODY,1. TRANSGENIC DNA SPLICING / GENE KNOCK OUT,2. LIBRARIES a.BACTERIOPHAGE b.

30、mRNA c. Cell Surface,3.Gene engineering Ab,Abs prepared by the method of gene recombination Chimeric Ab:human Fc bind with mice Fab Recombinant single chain Ab:VH-linker-VL,Human-mouse chimeric Ab,Niels K Jerne J.Kohler S.Milstein,Germany Basel Institute for Immunology Basel, Switzerland,Denmark Basel Institute for Immunology Basel, Switzerland,Argentina MRC Laboratory of Molecular Biology Cambridge,

展开阅读全文
相关资源
猜你喜欢
相关搜索

当前位置:首页 > 其他


经营许可证编号:宁ICP备18001539号-1